echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: What is the clinical specificity of cerebral venous thrombosis?

    Neurology: What is the clinical specificity of cerebral venous thrombosis?

    • Last Update: 2021-09-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cerebral vein thrombosis (CVT) is a rare and serious disease
    .


    Its morbidity rate is on the rise, as high as 1-57/100,000/year, and its mortality rate is declining


    Thrombosis in children

    The sex ratio varies with age .
    Newborns 5 and 6 are primarily male at first, while young adults are mainly female, and it does not persist among the elderly
    .

    , Newborns 5 and 6 are mainly male at first, while young and middle-aged people are mainly female, and they do not persist among the elderly
    .


    Studies have shown that there are important differences between men and women in the etiology, clinical manifestations and prognosis of CVT
    .

    Adolescence is a very special period in life.
    It is not just a transition from childhood to adulthood.
    In terms of health issues, it needs to be considered separately
    .


    In fact, adolescence seems to be a critical age during which neurological diseases can have a huge impact on all aspects of patients’ lives


    For example, the specific cause and course of adolescent arterial stroke have been shown
    .


    For venous thromboembolic diseases, the age distribution shows that the incidence of adolescents has reached a peak


    There is no specific research on CVT during adolescence



    They included 102 patients (52-9% were women; median age was 15-1 years)
    .


    The estimated incidence is 0-37-0-38/100,000 adolescents/year


    epilepsy

    The lateral sinus is the most common location for CVT (72-3%), and 29-4% of adolescents have related venous infarctions and/or hematomas
    .


    Most patients (94-1%) received anticoagulant therapy


    Blood vessel

    The most common CVT-related conditions are local infection in male patients (18-6%) and systemic disease in female patients (14-8%; P<0-001)
    .

    Infect

    The proportion of CVT in adolescents with no identified related diseases or risk factors is very low (1-9% vs 11-4% of adults; P<0-002)
    .


    Adverse consequences after 1 year are more common than adults (33-3% vs 11-8%; p=0-0001)


    CVT in adolescents is rare and complex, with special epidemiological characteristics , including differences in clinical manifestations and related conditions between different sexes, as well as more serious results than adults
    .


    Therefore, careful specialized management and follow-up are recommended
    .

    CVT in adolescents is rare and complex, with special epidemiological characteristics


    Original source:
    Devianne J, Legris N, Crassard I, et al.
    Epidemiology, Clinical Features, and Outcome in a Cohort of Adolescents With Cerebral Venous Thrombosis .
    Neurology.
    Published online September 20, 2021:10.
    1212/WNL.
    0000000000012828.
    doi:10.
    1212 /WNL.
    0000000000012828

    Epidemiology, Clinical Features, and Outcome in a Cohort of Adolescents With Cerebral Venous Thrombosis in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.